Abstract

The p70 ribosomal S6 kinase (S6K) family is a group of highly conserved kinases in eukaryotes that regulates cell growth, cell proliferation, and stress response via modulating protein synthesis and ribosomal biogenesis. S6Ks are downstream effectors of the Target of Rapamycin (TOR) pathway, which connects nutrient and energy signaling to growth and homeostasis, under normal and stress conditions. The plant S6K family includes two isoforms, S6K1 and S6K2, which, despite their high level of sequence similarity, have distinct functions and regulation mechanisms. Significant advances on the characterization of human S6Ks have occurred in the past few years, while studies on plant S6Ks are scarce. In this article, we review expression and activation of the two S6K isoforms in plants and we discuss their roles in mediating responses to stresses and developmental cues.

Highlights

  • A common feature of all living organisms is the ability to detect and respond to changes in the external environment such as drought, flooding, extreme temperatures, or pathogen infections, which are major yield-limiting factors (Alcazar et al, 2006)

  • Earlier experiments by Turck et al (Turck et al, 1998) showed that rapamycin treatment of human 293 cells induced a reduction in ribosomal protein S6 (rpS6) phosphorylation, which was rescued by transient expression of AtS6K2

  • It is suggested that the phosphorylation of rpS6 by S6 kinase (S6K) downstream of the Target of Rapamycin (TOR) pathway is needed to promote protein synthesis required for growth processes (Ren et al, 2012)

Read more

Summary

Introduction

A common feature of all living organisms is the ability to detect and respond to changes in the external environment such as drought, flooding, extreme temperatures, or pathogen infections, which are major yield-limiting factors (Alcazar et al, 2006). This would suggest that, at least in maize tissues, rpS6 phosphorylation regulates translation of specific proteins downstream of auxin signaling (Beltran-Pena et al, 2002). Earlier experiments by Turck et al (Turck et al, 1998) showed that rapamycin treatment of human 293 cells induced a reduction in rpS6 phosphorylation, which was rescued by transient expression of AtS6K2.

Results
Conclusion
Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.